1st Edition
Therapeutic Mushrooms for Diabetes Mellitus Current Evidences and Future Scope
This new book provides valuable insight into the role of mushrooms in the treatment of diabetes mellitus. Mushrooms are enriched with various bioactive constituents with antidiabetic efficacy such as polysaccharides, terpenes, sterols, etc. The extracts as well as bioactive constituents through different mechanisms exhibit antidiabetic action. Medicinal mushrooms such as Ganoderma lucidum, Innotus obliquus, Grifola frondosa, Phellinus species, etc. are considered in this volume for their beneficial qualities toward the mitigation of the disease. The volume considers mushroom powders, mushroom extracts, and their bioactive components for the management of diabetic syndrome. It presents various in vitro, in vivo, and clinical studies on lowering hyperglycemia and other diabetes associated with secondary abnormalities as well as provides information regarding mushroom-based antidiabetic market products.
1. Diabetes Mellitus: A Health Syndrome
Lena Ahmed Saleh Al-Faqeeh
2. Natural Products for the Management of Diabetes: Achievements and Future Trends
Kundan Singh Bora and Richa Shri
3. Human Medicinal Mushrooms Use
Mariano Torres-Gómez
4. Bioactive Constituents from Mushrooms for the Management of Diabetes: A Scientific Corroboration
Varinder Singh, Shiveena Bhatia, and Richa Shri
5. Mechanism of Actions of Antidiabetic Mushrooms
Wasim Sajad Malik, Mohd Yaqub Bhat, Abdul Hamid Wani, Anees Un Nisa, and Latif A. Peer
6. Effects of Mushrooms in Gestational Diabetes Mellitus
Mohd Yaqub Bhat, Asif Hamid Dar, Abdul Hamid Wani, Aadil Rashid Sheikh, Wasim Sajad Malik, and Pallaki Shrikhandia
7. Role of Mushrooms in the Prevention of Glycation and Other Secondary Complications
Varsha Mahesh Mayekar, Hina Alim, Ahmad Ali, and Nimisha Patel
8. In vitro Evaluation of the Antidiabetic Efficacy of Mushrooms
Asif Hamid Dar, Abdul Hamid Wani, Mohd Yaqub Bhat, Mehrajud din Talie, and Nayeema Jan
9. In vivo Appraisal and Clinical Trials of the Antidiabetic Potential of Mushrooms
Ashrafalsadat Hatamian-Zarmi, Hale Alvandi, Soheil Kianirad, Elham Ansari, Bahman Ebrahimi-Hoseinzadeh, and Zahra Beagom Mokhtari Hosseini
10. Antidiabetic Mushrooms: Market Products, Safety and Challenges
Harwinder K., Mridu, and Amita
Biography
Uzma Azeem, PhD, is affiliated with the Sanmati Government College of Science Education and Research, Ludhiana, Punjab, India. She was formerly Assistant Professor in the Department of Botany and Environmental Sciences at Sri Guru Granth Sahib World University, Punjab, India. To date, she has authored 11 papers in peer-reviewed national and international journals and one book, Fungi for Human Health: Current Knowledge and Future Perspectives (Springer Nature). Dr. Azeem earned her MPhil and doctorate in Botany with specialization in Mycology and Plant Pathology at Punjabi University, India.
Khalid Rehman Hakeem, PhD, is Professor at King Abdulaziz University, Jeddah, Saudi Arabia. He was formerly a lecturer, fellow, and researcher at the University of Kashmir, Srinagar, India, and at Universiti Putra Malaysia, Selangor, Malaysia. Dr. Hakeem has more than 10 years of teaching and research experience in plant eco-physiology, biotechnology and molecular biology, medicinal plant research, plant-microbe-soil interactions, as well as in environmental studies. He has served as a visiting scientist at Jinan University, Guangzhou, China. Dr. Hakeem has authored and edited more than 80 books with international publishers. He also has to his credit more than 180 research publications in peer-reviewed international journals and 75 book chapters in edited volumes. At present, Dr. Hakeem serves as an editorial board member and reviewer for several high-impact international scientific journals. He is included in the advisory board of Cambridge Scholars Publishing, UK.
